Darling Ingredients Earnings Momentum Reframes Long-Term Investment Narrative

Simply Wall St··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Darling Ingredients has drawn attention as analysts highlight its history of outperforming earnings estimates and a positive setup for its upcoming quarterly report. The company delivered US$1,550.82 million in sales and US$134.31 million in net income in the first quarter of 2026, reversing a loss a year earlier. Its long-term narrative projects US$7.2 billion in revenue and US$676.3 million in earnings by 2029, requiring 5.4% yearly revenue growth and a US$613.5 million earnings increase from US$62.8 million today. Some analysts hold a more cautious view, assuming revenue grows only about 2.5% a year and earnings reach roughly US$750.7 million by 2029. The renewed confidence around earnings surprises interacts with the existing investment case centered on renewable fuels, value-added ingredients, and policy tailwinds, while near-term risks remain around policy and margin volatility in renewable diesel.

Impact on assets 1

Synthetic Biology (non-pharma)▲ · 1 stocks
Darling Ingredients Inc
DAR
▲ PositiveCapitalrelevance

Analysts highlight earnings momentum and positive setup for upcoming report, with Q1 2026 reversing a loss.